These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25911134)

  • 21. Use of all-trans retinoic acid in combination with arsenic trioxide for remission induction in patients with newly diagnosed acute promyelocytic leukemia and for consolidation/maintenance in CR patients.
    Dai CW; Zhang GS; Shen JK; Zheng WL; Pei MF; Xu YX; Cao YX; Yi Y; Yang JJ; Peng HL; Zhong HY; Li RJ
    Acta Haematol; 2009; 121(1):1-8. PubMed ID: 19246888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Successful treatment of acute promyelocytic leukemia in a pregnant patient with all-trans retinoic acid and chemotherapy resulting in a safe delivery].
    Itoh M; Takao S; Yago K; Shimada H
    Rinsho Ketsueki; 2003 Jun; 44(6):401-3. PubMed ID: 12884820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of acute promyelocytic leukemia relapse in the ATRA era.
    Castagnola C; Lunghi M; Corso A; Tajana M; Zappasodi P; Dabusti M; Lazzarino M; Bernasconi C
    Haematologica; 1998 Aug; 83(8):714-7. PubMed ID: 9793255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute promyelocytic leukemia and pregnancy. A case report.
    Hoffman MA; Wiernik PH; Kleiner GJ
    Cancer; 1995 Dec; 76(11):2237-41. PubMed ID: 8635026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pregnancy in acute promyelocytic leukaemia after front-line therapy with arsenic trioxide and all-trans retinoic acid.
    Breccia M; Molica M; Efficace F; Minotti C; Latagliata R; Foà R; Lo Coco F
    Br J Haematol; 2014 Nov; 167(3):428-30. PubMed ID: 24957334
    [No Abstract]   [Full Text] [Related]  

  • 26. Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early intervention.
    Esteve J; Escoda L; Martín G; Rubio V; Díaz-Mediavilla J; González M; Rivas C; Alvarez C; González San Miguel JD; Brunet S; Tomás JF; Tormo M; Sayas MJ; Sánchez Godoy P; Colomer D; Bolufer P; Sanz MA;
    Leukemia; 2007 Mar; 21(3):446-52. PubMed ID: 17205057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term efficacy of low-dose all-trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post-remission therapy in newly diagnosed acute promyelocytic leukaemia.
    Lou Y; Qian W; Meng H; Mai W; Tong H; Tong Y; Huang J; Jin J
    Hematol Oncol; 2014 Mar; 32(1):40-6. PubMed ID: 23963734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Acute promyelocytic leukemia: results of the Chilean protocol LPA2000].
    Undurraga MS; Puga B; Cabrera ME; Palma T; Rossle A; Vergara CG; Rojas B; Aspillaga A
    Rev Med Chil; 2013 Oct; 141(10):1231-9. PubMed ID: 24522350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia.
    Schlenk RF; Germing U; Hartmann F; Glasmacher A; Fischer JT; del Valle y Fuentes F; Götze K; Pralle H; Nerl C; Salwender H; Grimminger W; Petzer A; Hensel M; Benner A; Zick L; Döhner K; Fröhling S; Döhner H;
    Leukemia; 2005 Jun; 19(6):978-83. PubMed ID: 15843821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of elderly patients (> or =60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocols.
    Mandelli F; Latagliata R; Avvisati G; Fazi P; Rodeghiero F; Leoni F; Gobbi M; Nobile F; Gallo E; Fanin R; Amadori S; Vignetti M; Fioritoni G; Ferrara F; Peta A; Giustolisi R; Broccia G; Petti MC; Lo-Coco F;
    Leukemia; 2003 Jun; 17(6):1085-90. PubMed ID: 12764372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin.
    de la Serna J; Montesinos P; Vellenga E; Rayón C; Parody R; León A; Esteve J; Bergua JM; Milone G; Debén G; Rivas C; González M; Tormo M; Díaz-Mediavilla J; González JD; Negri S; Amutio E; Brunet S; Lowenberg B; Sanz MA
    Blood; 2008 Apr; 111(7):3395-402. PubMed ID: 18195095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disappearance of PML/RAR alpha acute promyelocytic leukemia-associated transcript during consolidation chemotherapy.
    Martinelli G; Ottaviani E; Testoni N; Visani G; Diverio D; D'Elia G; Mandelli F; Tura S
    Haematologica; 1998 Nov; 83(11):985-8. PubMed ID: 9864917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of late cardiomyopathy by magnetic resonance imaging in patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and idarubicin.
    Rodríguez-Veiga R; Igual B; Montesinos P; Tormo M; Sayas MJ; Linares M; Fernández JM; Salvador A; Maceira-González A; Estornell J; Calabuig M; Pedreño M; Roig M; Sanz J; Sanz G; Carretero C; Boluda B; Martínez-Cuadrón D; Sanz MÁ;
    Ann Hematol; 2017 Jul; 96(7):1077-1084. PubMed ID: 28451804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New strategies for the treatment of acute promyelocytic leukaemia.
    Mandelli F
    J Intern Med Suppl; 1997; 740():23-7. PubMed ID: 9350178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two cycles of risk-adapted consolidation therapy in patients with acute promyelocytic leukemia. Results from the SAL-AIDA2000 trial.
    Röllig C; Schäfer-Eckardt K; Hänel M; Kramer M; Schaich M; Thiede C; Oelschlägel U; Mohr B; Wagner T; Einsele H; Krause SW; Bodenstein H; Martin S; Stuhlmann R; Ho AD; Bornhäuser M; Ehninger G; Schuler U; Platzbecker U
    Ann Hematol; 2015 Apr; 94(4):557-63. PubMed ID: 25366167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arsenic trioxide- and idarubicin-induced remissions in relapsed acute promyelocytic leukaemia: clinicopathological and molecular features of a pilot study.
    Kwong YL; Au WY; Chim CS; Pang A; Suen C; Liang R
    Am J Hematol; 2001 Apr; 66(4):274-9. PubMed ID: 11279639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A neonate born to a mother with acute promyelocytic leukemia treated by all-trans retinoic acid].
    Maeda M; Tyugu H; Okubo T; Yamamoto M; Nakamura K; Dan K
    Rinsho Ketsueki; 1997 Sep; 38(9):770-5. PubMed ID: 9364869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. All-trans retinoic acid therapy in relapsed/refractory or newly diagnosed acute promyelocytic leukemia (APL) in Japan.
    Ohno R; Ohnishi K; Takeshita A; Tanimoto M; Murakami H; Kanamaru A; Asou N; Kobayashi T; Kuriyama K; Ohmoto E
    Leukemia; 1994; 8 Suppl 3():S64-9. PubMed ID: 7808028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute leukemia during pregnancy: an investigative survey of the past 11 years.
    Nakajima Y; Hattori Y; Ito S; Ohshima R; Kuwabara H; Machida S; Shirasugi Y; Miyazaki K; Sakai R; Tomita N; Ando K; Higashihara M; Ishigatsubo Y; Fujisawa S
    Int J Lab Hematol; 2015 Apr; 37(2):174-80. PubMed ID: 24845193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracyclin based protocol. A report of the Spanish group PETHEMA.
    Hernández JM; Martín G; Gutiérrez NC; Cervera J; Ferro MT; Calasanz MJ; Martínez-Climent JA; Luño E; Tormo M; Rayón C; Díaz-Mediavilla J; González M; González-San Miguel JD; Pérez-Equiza K; Rivas C; Esteve J; Alvarez Mdel C; Odriozola J; Ribera JM; Sanz MA;
    Haematologica; 2001 Aug; 86(8):807-13. PubMed ID: 11522536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.